Evidence map›Paper›PMID 32945735›Full record

Trial reportThe Journal of urology2021

Efficacy of Daily Intake of Dried Cranberry 500 mg in Women with Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled Study.

Ahra Cho, Andrew Eidelberg, Daniel J Butler, David Danko, Ebrahim Afshinnekoo, Christopher E Mason, Bilal Chughtai

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05557279 (Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks - a Single-center Study), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05557279 phase2completednot on this mapstarted 2023, after this paper: background citation

Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks - a Single-center Study

TypeinterventionalSponsorLoyola UniversityRan2023 to 2025Enrolled53ConditionsOveractive BladderArms500 mg NDS-446
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ahra ChoDepartment of Urology, Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York.
Andrew EidelbergDepartment of Urology, Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York.
Daniel J ButlerTri-Institutional Computational Biology & Medicine Program, Weill Cornell Medicine, New York, New York.
David DankoTri-Institutional Computational Biology & Medicine Program, Weill Cornell Medicine, New York, New York.
Ebrahim AfshinnekooTri-Institutional Computational Biology & Medicine Program, Weill Cornell Medicine, New York, New York.
Christopher E MasonTri-Institutional Computational Biology & Medicine Program, Weill Cornell Medicine, New York, New York.
Bilal ChughtaiDepartment of Urology, Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York.

Funding

Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
NCATS NIH HHS UL1 TR002384
6 · The paper itself

Abstract

purposeWe sought to determine the efficacy of dried cranberry on reducing symptoms of overactive bladder in women. MATERIALS AND

methodsEligible women aged 18 or older with overactive bladder were randomized to either daily dried cranberry powder (500 mg) or placebo (500 mg) and followed for 24 weeks. Efficacy was measured by 3-day voiding diaries and Overactive Bladder Questionnaire Short Form, Patient Perception of Bladder Condition, Sexual Quality of Life-Female and Pelvic Floor Distress Inventory surveys. Statistical analyses were performed by BIOFORTIS using SAS® software version 9.4.

resultsOf the 98 women who were randomized 77 completed all the visits and 60 were included in the per protocol analysis. Compared to placebo using per protocol analysis the cranberry group showed a significant reduction of daily micturitions (-1.91, 95% CI -3.74--0.88, p=0.0406), urgency episodes (-2.81, 95% CI -4.82--0.80, p=0.0069), and Patient Perception of Bladder Condition scores (-0.66, 95% CI -1.23-0.08, p=0.0258) at 24 weeks of followup. Mean volume per micturition, nocturia and the remaining survey outcomes did not differ significantly between the groups (p >0.05).

conclusionsDaily intake of dried cranberry powder reduced daily micturition by 16.4%, urgency episodes by 57.3% and patient perception of bladder condition by 39.7%. However, an intent-to-treat analysis showed no statistically significant difference between the groups for these measurements (p >0.05). Future larger studies with longer followup periods are needed to further determine the long-term effect of cranberry on overactive bladder.

Indexed as

PhytotherapyVaccinium macrocarponAdultDouble-Blind MethodDrug Administration ScheduleFemaleHumansMiddle AgedTreatment OutcomeUrinary Bladder, Overactiveurinary bladder, overactiveurinationurination disorders, perceptionVaccinium macrocarpon

Identifiers

PMID32945735
PMCPMC8299659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.